Systemic Inflammatory Response Syndrome Clinical Trial
Official title:
Can Biomarkers Aid in the Prediction of Postoperative Pain and Circulatory Instability After Major Abdominal Surgery? A Prospective Observational Study
NCT number | NCT02563652 |
Other study ID # | 2015/641 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 2015 |
Est. completion date | September 2018 |
Verified date | November 2018 |
Source | St. Olavs Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Patients undergoing major surgery are exposed to extensive damage of tissues, which induces
widespread activation of the inflammatory system, called 'systemic inflammatory response
syndrome' (SIRS).This activation of the inflammatory system may induce instability of the
heart and respiration in the postoperative period. The degree of physiologic response to
postoperative SIRS as well as the degree of postoperative pain differ between patients.
Therefore, patients undergoing anesthesia and major surgery are treated in a 'post anesthesia
care unit' (PACU) after end of surgery.Admittance to a PACU is expensive. The time patients
need to stay in a PACU after major surgery has not been extensively studied, and more
appropriate tools for prediction of length of stay are needed.
The main aim of this study is to assess whether clinical observations, inflammatory
biomarkers or genetic markers may aid in the prediction of physiological instability and/or
pain after major surgery. Such predictors would help clinicians planning the length of
PACU-stays.
Status | Completed |
Enrollment | 101 |
Est. completion date | September 2018 |
Est. primary completion date | September 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients undergoing major abdominal surgery (e.g. Whipple's operation, liver resection, abdominoperineal resection, vascular abdominal surgery etc.) - Scheduled for PACU stay first 24 hours Exclusion Criteria: - Pregnancy - Jehovah's witness - Dementia |
Country | Name | City | State |
---|---|---|---|
Italy | University of Parma | Parma | |
Norway | St Olavs Hospital | Trondheim |
Lead Sponsor | Collaborator |
---|---|
St. Olavs Hospital | IRCCS Policlinico S. Matteo, Study in Multidisciplinary Pain Research Group, Italy, University of Parma |
Italy, Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to established circulatory stability for > 2 hours [Time to event outcome] | Circulatory stability will be assessed by applying a multi-state statistical model, where any state changes are measured at an hourly basis. The model will include variables reflecting the circulatory state of the patient, including heart rate, systolic blood pressure (or MAP) and lactate, which will be assessed together with the measures needed to maintain them, such as the amount of fluid given (ml per hour) and the extent of vasopressor (i.e. norepinephrine). The main outcome variable will be the time needed to reach the state of 'stable without intervention for more than two hours. To be classified in this state, the systolic blood pressure must be > 100 mmHg, the heart rate between 40 and 110, the patient must be off vasopressor and has a fluid requirement of less than 250 ml/hour. | 48 hours | |
Primary | Time to reaching a state of no or mild pain problem for > 2 hours [Time to event outcome] | This outcome will be reached when the patient has a numeric rating score (NRS) with respect to pain of < 4 and the opioid consumption is less than 5 mg morphine equivalents per hour. | 48 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02902939 -
Myeloid-Derived Supressor Cells in Cardiac Surgery Patients
|
N/A | |
Completed |
NCT02518087 -
Increased Adsorption Membranes During Cardiopulmonary Bypass
|
N/A | |
Recruiting |
NCT01157299 -
Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO
|
N/A | |
Completed |
NCT01388725 -
Comparison the Value of Several Biomarkers of Sepsis
|
N/A | |
Unknown status |
NCT00254176 -
Cysteine Supplementation in Critically Ill Neonates
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03617796 -
Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
|
||
Completed |
NCT03876041 -
Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome
|
Phase 4 | |
Recruiting |
NCT05608096 -
European Registry for Hemadsorption in Sepsis With the Seraph Filter
|
||
Completed |
NCT03314831 -
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
|
||
Completed |
NCT02568410 -
Platelets as Regulators of Inflammation in Cardiac Surgery
|
||
Completed |
NCT01636232 -
Vitamin D and Critically Ill Patients
|
N/A | |
Completed |
NCT01020409 -
INFLACOR - Clinical and Genetic Predictors of Inflammation Related Complications After Heart Surgery
|
Phase 4 | |
Completed |
NCT04624776 -
Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest
|
Phase 2 | |
Recruiting |
NCT05172739 -
Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC
|
Phase 4 | |
Recruiting |
NCT02957175 -
Immunophenotyping of Patients With Postoperative SIRS
|
||
Completed |
NCT02320539 -
MicroRNA Diagnostics in Subarachnoid Hemorrhage 2
|
N/A | |
Completed |
NCT01708759 -
IL8 Monitoring and Its Correlation With 251-gene Polymorphism
|
N/A | |
Terminated |
NCT00708799 -
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
|
Phase 2 | |
Recruiting |
NCT04580680 -
Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)
|
||
Recruiting |
NCT05663216 -
Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome
|